Law360, New York (August 27, 2008, 12:00 AM ET) -- Abbott Laboratories has won approval to seek interlocutory appeal of some contentious antitrust issues that have arisen in one of several suits the company is facing for allegedly jacking up the price of its HIV medication Norvir, paving the way for a proposed settlement upon which the appeal is predicated.
Judge Claudia Wilken said in a ruling Wednesday in the U.S. District Court for the Northern District of California that the pharmaceutical giant may apply for an interlocutory appeal to the U.S. Court of Appeals for...
Abbott's Appeal, Deal OK'd In Norvir Antitrust Case
To view the full article, take a free trial now.
